Auto Injector Market - Forecasts from 2019 to 2024

The auto injector market is projected to grow at a CAGR of 8.02% to reach US$1.976 billion by 2024, from US$1.244 billion in 2018. An auto injector is defined as a medical device designed to inject a single dose of particular drugs. Auto injectors are easy to use, spring loaded syringes intended for self-administration by the patients or even untrained personnel. The site of the injection usually depends on the drug to be delivered, however, intramuscular is the preferred site for the drug delivery. Currently, auto injectors are used to deliver drugs for diseases such as multiple sclerosis, severe allergic reactions or anaphylactic shock and rheumatoid arthritis. The auto injector market is expected to show significant growth in the given forecast period. The growth may be attributed to the rising number of patients adopting auto injectors due to the ease of administration. Continuous technological development coupled with the increased patient compliance to auto injectors will also augment the market growth for the auto injectors. However, the high cost of these injectors as compared to the traditional injections or drug delivery methods will restrain the market growth during the given time frame.

Drivers

Prevalence of chronic diseases worldwide.

Convenient to use for self-administration.

Growing health expenditure worldwide.

Restraints

Stringent regulations regarding the development and approval of auto injector devices.

The high cost of auto-injectors in comparison to the traditional injections.

Industry Update

On January 2019, SHL Group announced its plan for expansion in Taiwan and create 800 new jobs in order to support the increase in productions for SHL Medical.

On November 2017, SHL Group announced that it has entered into a strategic partnership with healthcare start-up QuiO on digital technologies. This is further poised to take the drug delivery industry into connected therapeutics.

The major players profiled in the global auto injector market include ATS Automation Tooling Systems Inc., Owen Mumford Ltd., SHL Group, Ypsomed AG, Becton, Dickinson and Company, Oval Medical Technologies Ltd., E3D Elcam Drug Delivery Devices, kaleo, Inc., Crossject, and Gerresheimer AG.

Segmentation

The auto-injector market has been analyzed through the following segments:

By Usability

Reusable Auto injectors
Disposable Auto injectors

By Indication

Anaphylaxis
Rheumatoid arthritis
Multiple Sclerosis
Others

By Geography

North America
USA
Canada
Mexico

South America
Brazil
Argentina
Others

Europe
United Kingdom
Germany
France
Spain
Others

Middle East and Africa
Saudi Arabia
Israel
Others

Asia Pacific
China
Japan
South Korea
India
Others